Diffusible VP22-E2 protein kills bystander cells and offers a route for cervical cancer gene therapy.
about
Replication-competent herpes simplex virus 1 isolates selected from cells transfected with a bacterial artificial chromosome DNA lacking only the UL49 gene vary with respect to the defect in the UL41 gene encoding host shutoff RNase.Controversies surrounding human papilloma virus infection, head & neck vs oral cancer, implications for prophylaxis and treatment.
P2860
Diffusible VP22-E2 protein kills bystander cells and offers a route for cervical cancer gene therapy.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Diffusible VP22-E2 protein kil ...... cervical cancer gene therapy.
@en
Diffusible VP22-E2 protein kil ...... cervical cancer gene therapy.
@nl
type
label
Diffusible VP22-E2 protein kil ...... cervical cancer gene therapy.
@en
Diffusible VP22-E2 protein kil ...... cervical cancer gene therapy.
@nl
prefLabel
Diffusible VP22-E2 protein kil ...... cervical cancer gene therapy.
@en
Diffusible VP22-E2 protein kil ...... cervical cancer gene therapy.
@nl
P2093
P356
P1433
P1476
Diffusible VP22-E2 protein kil ...... r cervical cancer gene therapy
@en
P2093
Kate Mulryan
Katie L Green
Lez J Fairbairn
Tom D Southgate
P304
P356
10.1089/HUM.2006.17.147
P577
2006-02-01T00:00:00Z